Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion.

Grady B, van den Berg C, van der Helm J, Schinkel J, Coutinho R, Krol A, Prins M.

Clin Gastroenterol Hepatol. 2011 Sep;9(9):786-792.e1. doi: 10.1016/j.cgh.2011.05.012. Epub 2011 May 20.

PMID:
21699803
2.

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, Fumolo E, Bignulin S, Fontanini E, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Clin Immunol. 2011 Oct;31(5):891-9. doi: 10.1007/s10875-011-9547-1. Epub 2011 Jun 7.

PMID:
21647799
3.

Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort.

Clausen LN, Weis N, Astvad K, Schønning K, Fenger M, Krarup H, Bukh J, Benfield T.

J Viral Hepat. 2011 Apr;18(4):e66-74. doi: 10.1111/j.1365-2893.2010.01392.x. Epub 2010 Nov 12.

PMID:
21070502
4.

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ; ATAHC Study Group.

Hepatology. 2010 Oct;52(4):1216-24. doi: 10.1002/hep.23850.

5.

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J; German Anti-D Study Group.

Gastroenterology. 2010 Nov;139(5):1586-92, 1592.e1. doi: 10.1053/j.gastro.2010.07.005. Epub 2010 Jul 14.

PMID:
20637200
6.

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY; Swiss Hepatitis C Cohort Study; Swiss HIV Cohort Study.

Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7. doi: 10.1053/j.gastro.2009.12.056. Epub 2010 Jan 11.

PMID:
20060832
7.

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP.

J Infect Dis. 2009 Oct 15;200(8):1216-26. doi: 10.1086/605947.

8.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M.

Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.

9.

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J.

Nat Genet. 2009 Oct;41(10):1100-4. doi: 10.1038/ng.447. Epub 2009 Sep 13.

PMID:
19749758
10.

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M.

Nat Genet. 2009 Oct;41(10):1105-9. doi: 10.1038/ng.449. Epub 2009 Sep 13.

PMID:
19749757
11.

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB.

Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.

PMID:
19684573
12.

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A; HepaICONA and the ICONA Study Groups.

Infection. 2009 Oct;37(5):445-9. doi: 10.1007/s15010-008-8194-9. Epub 2009 Aug 7.

PMID:
19669092
13.

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

van de Laar TJ, Molenkamp R, van den Berg C, Schinkel J, Beld MG, Prins M, Coutinho RA, Bruisten SM.

J Hepatol. 2009 Oct;51(4):667-74. doi: 10.1016/j.jhep.2009.05.027. Epub 2009 Jun 18.

PMID:
19646773
14.

HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.

Sagnelli E, Coppola N, Pisaturo M, Masiello A, Tonziello G, Sagnelli C, Messina V, Filippini P.

Hepatology. 2009 Apr;49(4):1090-7. doi: 10.1002/hep.22794.

PMID:
19263473
15.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.

PMID:
18767985
16.

Acute HCV in HIV-positive individuals - a review.

Danta M, Dusheiko GM.

Curr Pharm Des. 2008;14(17):1690-7. Review.

PMID:
18673193
17.

Acute hepatitis C: a systematic review.

Kamal SM.

Am J Gastroenterol. 2008 May;103(5):1283-97; quiz 1298. doi: 10.1111/j.1572-0241.2008.01825.x. Review.

PMID:
18477352
18.

Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.

Operskalski EA, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, Villacres MC, Spencer LY, Degiacomo M, Kovacs A.

J Clin Virol. 2008 Apr;41(4):255-63. doi: 10.1016/j.jcv.2007.08.021. Epub 2008 Feb 20.

19.

HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.

Ruys TA, Nanlohy NM, van den Berg CH, Hassink E, Beld M, van de Laar T, Bruisten S, Wit F, Krol A, Prins M, Lange J, van Baarle D.

J Viral Hepat. 2008 Jun;15(6):409-20. doi: 10.1111/j.1365-2893.2007.00963.x. Epub 2008 Jan 22.

PMID:
18221302
20.

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR.

J Infect Dis. 2007 Nov 15;196(10):1474-82. Epub 2007 Oct 31.

PMID:
18008226

Supplemental Content

Support Center